Filtricine
Developing a drug-free cancer therapy based on nutrient deprivation
Filtricine is active in the biopharma space based in United States, founded in 2017.
Profile
Filtricine, Inc. is a pre-clinical-stage therapeutic company. For cancer patients who want effective, safe, and long-lasting treatment, Filtricine is developing a drug-free cancer therapy based on nutrient deprivation. By precisely taking away the nutrients that are necessary only for cancer cells, the therapy kills only the cancer—not the patient.
Filtricine is positioned in biopharma, a segment that rewards a clear, focused offering.
Its base of operations is United States.
Its current recorded stage is SOSV portfolio company.
Its team size is recorded as 2-10 employees.
| Sector | Biopharma |
|---|---|
| Country | United States |
| Founded | 2017 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
Website: filtricine.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account